Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Cerus Corp
(NQ:
CERS
)
6.165
USD
-0.185 (-2.91%)
Streaming Delayed Price
Updated: 1:45 PM EDT, Apr 16, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Cerus Corp
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
16
17
Next >
Cerus Prices $70.0 Million Public Offering of Common Stock
January 07, 2015
From
Business Wire News Releases
Cerus Announces Proposed Public Offering of Common Stock
January 05, 2015
From
Business Wire News Releases
Cerus Reports EU Phase 3 Clinical Trial of INTERCEPT Red Blood Cells Met Primary Endpoint
January 04, 2015
From
Business Wire News Releases
Cerus Reports US Phase 2 Clinical Trial of INTERCEPT Red Blood Cells Met Primary Endpoint
December 22, 2014
From
Business Wire News Releases
FDA Approves INTERCEPT Blood System for Platelets
December 18, 2014
From
Business Wire News Releases
Stocks in the News: Analyst Coverage on Encana, Unisys, Salix, Cerus and Eli Lilly
December 17, 2014
Editor Note: For more information about this release, please scroll to bottom.
From
PR Newswire
FDA Approves INTERCEPT Blood System for Plasma
December 16, 2014
From
Business Wire News Releases
Health Care Equipment and Supplies Equities Scrutiny - Abbott Laboratories, Zimmer Holdings, Varian Medical Systems, Edwards Lifesciences, and Cerus
December 11, 2014
Editor Note: For more information about this release, please scroll to bottom.
From
PR Newswire
FDA Accepts IDE Supplement for INTERCEPT Blood System Treatment of Ebola Convalescent Plasma
November 21, 2014
From
Business Wire News Releases
Technical Updates on Health Care Supplies Sector Stocks - Align Technology, DENTSPLY Intl., Baxano Surgical, Cerus, and Alere
November 05, 2014
Editor Note: For more information about this release, please scroll to bottom.
From
PR Newswire
Cerus Corporation Reports Third Quarter 2014 Results
November 04, 2014
From
Business Wire News Releases
Cerus Announces Agreement With Kawasumi Laboratories for the Development of INTERCEPT Platelets Kits in Japan
October 29, 2014
From
Business Wire News Releases
American Red Cross to Participate in Cerus' IDE Study to Address Chikungunya and Dengue Blood Safety Risks
October 23, 2014
From
Business Wire News Releases
Cerus to Release Third Quarter 2014 Results on November 4, 2014
October 22, 2014
From
Business Wire News Releases
Cerus Submits Compassionate Use IDE Supplement for INTERCEPT Blood System Treatment of Ebola Convalescent Plasma
October 20, 2014
From
Business Wire News Releases
U.S. FDA Accepts IDE Submission by Cerus Making the INTERCEPT Blood System Available to Address Chikungunya and Dengue Blood Safety Risks
October 07, 2014
From
Business Wire News Releases
Cerus and Biomedica Foscama Group S.p.A. Enter Distribution Agreement for the INTERCEPT Blood System in Italy
September 11, 2014
From
Business Wire News Releases
Cerus Submits IDE Supplement to Make INTERCEPT Platelets Available Pre-Approval in U.S. Areas at Risk from Outbreaks of Chikungunya and Dengue
September 10, 2014
From
Business Wire News Releases
Cerus to Present at the Morgan Stanley 2014 Global Health Care Conference on September 10, 2014
September 04, 2014
From
Business Wire News Releases
Cerus to Present at the Baird 2014 Health Care Conference on September 3, 2014
August 28, 2014
From
Business Wire News Releases
Cerus to Present at the Wedbush 2014 Life Sciences Management Access Conference on August 12, 2014
August 07, 2014
From
Business Wire News Releases
Cerus Corporation Reports Second Quarter 2014 Results
July 31, 2014
From
Business Wire News Releases
Cerus Submits Final Module in Premarket Approval (PMA) Application Process for INTERCEPT Platelets
July 17, 2014
From
Business Wire News Releases
Cerus to Release Second Quarter 2014 Results on July 31, 2014
July 17, 2014
From
Business Wire News Releases
Cerus Corporation Secures $30 Million Growth Capital Credit Facility From Oxford Finance
July 01, 2014
From
Business Wire News Releases
Market Movers - Health Care Sector Stocks -- Research on Cerus, Illumina, UnitedHealth, and WellCare Health Plans
June 04, 2014
Editor Note: For more information about this release, please scroll to bottom.
From
PR Newswire
Cerus Signs Five-Year Agreement With Belgian Red Cross Flanders for the INTERCEPT Blood System for Platelets
May 29, 2014
From
Business Wire News Releases
Technical Data on Top Gainers -- Research on MeetMe, Cerus, Durect, and Omeros
May 06, 2014
Editor Note: For more information about this release, please scroll to bottom.
From
PR Newswire
Cerus Corporation Reports First Quarter 2014 Results
May 01, 2014
From
Business Wire News Releases
Cerus Announces Collaboration Agreement With Nipro for Innovative INTERCEPT Red Blood Cell System Component
April 29, 2014
From
Business Wire News Releases
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.